Immunotherapeutic strategy to prevent progression and complications of acute rheumatic fever
Rukshan Ahamed Mohamed Rafeek, Natkunam Ketheesan, Michael F. Good, Manisha Pandey, Ailin Lepletier
This study investigates low-dose interleukin 2 (LD-IL-2) as an immunotherapeutic intervention in a rat model of acute rheumatic fever, showing reduced cardiac inflammation and increased regulatory T-cells.
mBio · Feb 25, 2025Peer-reviewedImmunology